A carregar cotações...
Previsão
Não temos dados de analistas para esta empresa.
Notícias Ir para o feed de notícias
IVF HARTMANN: half-year revenue and profit rose sharply
IVF HARTMANN increased revenue in the first half of 2026 by 11.3% to CHF 85.9 million. EBIT grew by 27.5% to CHF 12.1 million (margin 14.0%) and net profit rose by 24.7% to CHF 10.3 million, driven by new customers, temporary demand, innovative products, customer-specific services and digital solutions. A revenue increase is still expected for the full year, although growth in the second half is likely to be weaker; the EBIT forecast has been raised to a level above the previous year. The company cites as risks possible margin-pressure effects from falling prices relative to higher-valued inventories and long procurement processes in tactical operational medicine. » Mais em finanzen.net
Claus Martini steps down as CEO of IVF Hartmann after ten years
Claus Martini has resigned as CEO of IVF Hartmann after ten years at the helm. Further details about the resignation and succession were not given in the brief notice. » Mais em finanzen.net
Dividendos históricos Dividendos
Todos os indicadores de dividendos Todos os indicadoresDados financeiros da empresa
| (EUR) | junho de 2026 | |
|---|---|---|
| Receitas | 93,06 mi | - |
| Ganho bruto | 30,01 mi | - |
| Ganho líquido | 11,13 mi | - |
| EBITDA | 15,5 mi | - |
Dados fundamentais
| Métrica | Valor |
|---|---|
Capitalização bolsista | € 324,82 mi |
Número de ações | 2,4 mi |
Máximo/mínimo de 52 semanas | € 135,61 - € 111,24 |
Rentabilidade de dividendos | 3,06% |
Dividendos TTM | € 4,14 |
Beta | 0,23 |
PER (PE Ratio) | 14,86 |
PEG (PEG Ratio) | 2,28 |
P/VC (PB Ratio) | 1,92 |
P/V (PS Ratio) | 1,77 |
Perfil da empresa
Die IVF Hartmann Holding AG vertreibt medizinische Verbrauchsgüter in der Schweiz und international. Das Unternehmen bietet chirurgische Einweginstrumente, Decken, Kleidung und Handschuhe, Desinfektions- und Hygieneprodukte, Dienstleistungen für Wundmanagement und Hydrotherapie, Inkontinenzmanagement und Erste-Hilfe-Produkte sowie verschiedene Kurse an. Das Unternehmen beliefert niedergelassene Ärzte, die ambulante Medizin und Pflege, Krankenhäuser und Kliniken, Apotheken und Drogerien, Pflegeheime, den Medizin- und Lebensmitteleinzelhandel sowie Industriekunden. Das Unternehmen war früher unter dem Namen IVF bekannt und änderte 1993 seinen Namen in IVF Hartmann Holding AG. Das Unternehmen wurde 1874 gegründet und hat seinen Hauptsitz in Neuhausen am Rheinfall, Schweiz.
| Nome | IVF Hartmann |
| CEO | Martin Walther |
| Sede | Neuhausen am Rheinfall,
sh Suíça |
| Site | |
| Entrada em bolsa | 14/04/1995 |
| Colaboradores | 316 |
Análise aprofundada
Símbolos de ticker
| Bolsa | Símbolo |
|---|---|
SIX | VBSN.SW |
London Stock Exchange | 0QQM.L |
London | 0QQM.L |